Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2024-12-12 00:00:00 ET · period of report 2024-12-10 · accession 0001773751-24-000384 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-12 | 2024-12-10 | HIMS | Baird Melissa | COO | S - Sale+OE | $31.01 | -85.6K | 690.3K | -11% | -$2.65M |
| D | 2024-12-12 | 2024-12-10 | HIMS | Baird Melissa | COO | M - OptEx | $0.4 | +85.6K | 716.5K | +14% | +$34.2K |
| D | 2024-12-12 | 2024-12-10 | HIMS | Baird Melissa | COO | M - OptEx | $0.00 | -85.6K | 257.6K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-10 | S | D | 8,213 | $31.98 | 630,986 | D | — | — | (F5) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $31.86 - $32.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2024-12-10 | S | D | 51,082 | $31.09 | 639,199 | D | — | — | (F4) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.785 - $31.77. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Class A Common Stock | 2024-12-10 | S | D | 26,266 | $30.55 | 690,281 | D | — | — | (F2) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.785 - $30.78. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. (F3) Includes 820 shares acquired on November 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. |
| 4 | Common | Class A Common Stock | 2024-12-10 | M | A | 85,561 | $0.4 | 716,547 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2024-12-10 | M | D | 85,561 | $0.00 | 257,617 | D | $0.4 · — to 2028-03-28 | 85,561 Class A Common Stock | (F6) Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. |